Home > Healthcare > Biotechnology > Bioservices > Optical Genome Mapping (OGM) Market
Optical Genome Mapping Market was valued at USD 131.5 million in 2023 and is estimated to grow at a CAGR of 24.1% between 2024 and 2032. High market share can be attributed to factors such as increasing demand for precision medicine, rising government initiatives & funding, and growing collaborations between technology providers for genomic services
Also, advancements in optical mapping technologies such as improvements in speed, accuracy, and scalability, contribute significantly to the market's expansion. For instance, in January 2023, Bionano Genomics, Inc, launched multiple new products and advancements for its optical genome mapping (OGM) workflow that offer enhanced robustness in sample preparation. This enable to decrease the turnaround time for DNA labelling and imaging, and improvements in throughput and quality metrics. Thus, availability of such products and services along with the rising prevalence of genetic disorders & cancers has fuelled the need for advanced genomic tools, thereby accelerating the market expansion.
Optical genome mapping is a genomic technology that involves the analysis and mapping of DNA molecules at a high resolution. It provides a comprehensive view of the structure and arrangement of genomic DNA. By analysing the patterns and lengths of labelled DNA fragments, researchers can create a detailed map of the genome, identifying structural variations, copy number variations, and other genomic features.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Optical Genome Mapping Market Size in 2023: | USD 131.5 Million |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 24.1% |
2032 Value Projection: | USD 883.5 Million |
Historical Data for: | 2018 to 2023 |
No. of Pages: | 160 |
Tables, Charts & Figures: | 261 |
Segments covered: | Products & Services, Application, Solution, End-User, & Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|